Article
Silencing or inhibition of endoplasmic reticulum aminopeptidase 1 (ERAP1) suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis.
Annals of the rheumatic diseases - 1 May 2016
Chen Liye, Ridley Anna, Hammitzsch Ariane, Al-Mossawi Mohammad Hussein, Bunting Helen, Georgiadis Dimitris, Chan Antoni, Kollnberger Simon, Bowness Paul
Abstract excerpt
OBJECTIVE: Human leucocyte antigen (HLA)-B27 and endoplasmic reticulum aminopeptidase 1 (ERAP1) are strongly associated with ankylosing spondylitis (AS). ERAP1 is a key aminopeptidase in HLA class I presentation and can potentially alter surface expression of HLA-B27 free heavy chains (FHCs). We studied the effects of ERAP1 silencing/inhibition/variations on HLA-B27 FHC expression and Th17 responses in AS....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
